本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rapport Therapeutics, Inc.

41.39
-1.2900-3.02%
盤後41.390.00000.00%19:30 EDT
成交量:38.70萬
成交額:1,618.60萬
市值:19.86億
市盈率:-13.56
高:43.67
開:42.82
低:41.23
收:42.68
52周最高:52.93
52周最低:23.75
股本:4,797.83萬
流通股本:3,039.38萬
量比:1.39
換手率:1.27%
股息:- -
股息率:- -
每股收益(TTM):-3.0525
每股收益(LYR):-2.8633
淨資產收益率:-39.96%
總資產收益率:-25.78%
市淨率:4.70
市盈率(LYR):-14.46

資料載入中...

2025/01/10

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/18

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/20

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/14

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/06/10

重要事件披露

Form 8-K - Current report
2024/06/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/05

SEC問詢函

Form CORRESP - Correspondence
2024/06/05

SEC問詢函

Form CORRESP - Correspondence
2024/06/03

SEC問詢函

Form CORRESP - Correspondence
2024/06/03

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/30

SEC問詢函

Form CORRESP - Correspondence
2024/05/18

SEC問詢函

Form CORRESP - Correspondence
2024/05/17

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933